You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 5, 2026

A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
Published on: July 22, 2022
Jay J Meyer1,2, Kuan Li3, Bryce Christensen3
1Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, UT.
Individuals with Fuchs Endothelial Corneal Dystrophy (FECD) do not face an increased risk of developing most cancers. This large-scale study found no significant cancer risk alterations for FECD patients compared to the general population.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: